featured
Final OS Analysis of JUPITER-2: Incorporation of ICI in the First Line for Recurrent/Metastatic Nasopharyngeal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: